Regulation of ERBB3/HER3 signaling in cancer.
Regulation of ERBB3/HER3 signaling in cancer.
复制标题
DOI：
10.18632/oncotarget.2655
复制
发表时间：
2014-11-15
期刊：
影响因子：
--
通讯作者：
An Z
中科院分区：
文献类型：
--
作者：
Mujoo K;Choi BK;Huang Z;Zhang N;An Z
ERBB3/HER3 is emerging as a molecular target for various cancers. HER3 is overexpressed and activated in a number of cancer types under the conditions of acquired resistance to other HER family therapeutic interventions such as tyrosine kinase inhibitors and antibody therapies. Regulation of the HER3 expression and signaling involves numerous HER3 interacting proteins. These proteins include PI3K, Shc, and E3 ubiquitin ligases NEDD4 and Nrdp1. Furthermore, recent identification of a number of HER3 oncogenic mutations in colon and gastric cancers elucidate the role of HER3 in cancer development. Despite the strong evidence regarding the role of HER3 in cancer, the current understanding of the regulation of HER3 expression and activation requires additional research. Moreover, the lack of biomarkers for HER3-driven cancer poses a big challenge for the clinical development of HER3 targeting antibodies. Therefore, a better understanding of HER3 regulation should improve the strategies to therapeutically target HER3 for cancer therapy.
登录
查看更多内容
影响因子：
4.8
作者：
Chaib, H;Cockrell, EK;Macoska, JA
通讯作者：
Macoska, JA
影响因子：
5.6
作者：
Aurisicchio, Luigi;Marra, Emanuele;Ciliberto, Gennaro
通讯作者：
Ciliberto, Gennaro
影响因子：
7.3
作者：
Carraway KL 3rd
通讯作者：
Carraway KL 3rd
影响因子：
2.3
作者：
Abdullah, JM;Li, XY;Jurecic, R
通讯作者：
Jurecic, R
影响因子：
11.5
作者：
Desbois-Mouthon, Christele;Baron, Aurore;Rosmorduc, Olivier
通讯作者：
Rosmorduc, Olivier